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Background
Airway hyperresponsiveness (AHR) is one of the typical
characteristics of asthma, but its natural course is not
known. While asthmatics are under medical treatment,
whether their AHRs are present or not is hardly assessed.
In mild asthmatics, we investigate the change of AHR in
comparison to clinical parameters.
Methods
Patients diagnosed with asthma, but asymptomatic for
more than 3 months while undergoing medical treatment
were enrolled. AHR was measured through methacholine
bronchial provocation test after a 2-week wash-out per-
iod. AHR-negative was defined as PC20 is greater than
25mg/mL. Clinical parameters were compared retrospec-
tively between the AHR-negative and the AHR-positive
patients.
Results
Among 54 patients, 22 (40.7%) were AHR-negative. The
considerable factors for the maintenance of AHR is male
sex, presence of dyspnea at initial presentation and high
dose inhaled corticosteroid plus long acting beta agonist at
initial presentation (respectively, p < 0.05). Age, symptoms
other than dyspnea, blood tests, results of the spirometry,
diagnostic methods at presentation and time intervals
from diagnosis to follow-up tests showed no difference
between AHR-negativity and AHR-positivity. Multivari-
able analyses failed to show a statistical significance in the
two groups.
Conclusions
In mild asthmatics, about 40% might show no AHR, the
clinical remission of the disease. Changing AHR status in
mild asthma while undergoing medical treatment is not
predictable, so that cessation of regular controller medica-
tion might be advocated, and then a reassessment of AHR
should be mandatory.
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